Inspire Medical Systems Revenue 2017-2023 | INSP
Inspire Medical Systems annual/quarterly revenue history and growth rate from 2017 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Inspire Medical Systems revenue for the quarter ending December 31, 2023 was $0.193B, a 39.6% increase year-over-year.
- Inspire Medical Systems revenue for the twelve months ending December 31, 2023 was $0.625B, a 53.19% increase year-over-year.
- Inspire Medical Systems annual revenue for 2023 was $0.625B, a 53.19% increase from 2022.
- Inspire Medical Systems annual revenue for 2022 was $0.408B, a 74.75% increase from 2021.
- Inspire Medical Systems annual revenue for 2021 was $0.233B, a 102.28% increase from 2020.
| Inspire Medical Systems Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $625 |
| 2022 | $408 |
| 2021 | $233 |
| 2020 | $115 |
| 2019 | $82 |
| 2018 | $51 |
| 2017 | $29 |
| 2016 | $16 |
| Inspire Medical Systems Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | $193 |
| 2023-09-30 | $153 |
| 2023-06-30 | $151 |
| 2023-03-31 | $128 |
| 2022-12-31 | $138 |
| 2022-09-30 | $109 |
| 2022-06-30 | $91 |
| 2022-03-31 | $69 |
| 2021-12-31 | $78 |
| 2021-09-30 | $62 |
| 2021-06-30 | $53 |
| 2021-03-31 | $40 |
| 2020-12-31 | $46 |
| 2020-09-30 | $36 |
| 2020-06-30 | $12 |
| 2020-03-31 | $21 |
| 2019-12-31 | $27 |
| 2019-09-30 | $21 |
| 2019-06-30 | $18 |
| 2019-03-31 | $16 |
| 2018-12-31 | $17 |
| 2018-09-30 | $13 |
| 2018-06-30 | $11 |
| 2018-03-31 | $10 |
| 2017-12-31 | $10 |
| 2017-09-30 | $7 |
| 2017-06-30 | $6 |
| 2017-03-31 | $5 |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $7.194B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Enovis (ENOV) | United States | $3.030B | 23.02 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |